☆ 4.3 Article

H3K27me3 deficiency in dedifferentiated carcinoma and carcinosarcoma of the endometrium

VIRCHOWS ARCHIV (2023)

Related references

Note: Only part of the references are listed.

Article Cell Biology

Loss of H3K27 trimethylation in a distinct group of de-differentiated chordoma of the skull base

N. Makise et al.

Summary: This study investigated trimethylation at lysine 27 of histone 3 (H3K27me3) in de-differentiated chordomas and identified a distinct 'polycomb-type' de-differentiation pathway associated with EED homozygous deletion and MPNST-like histology. Understanding these mechanisms is important for further research on the pathogenesis of chordomas.

HISTOPATHOLOGY (2023)

Add to Collection

Article Cell Biology

Genomic profiling of dedifferentiated endometrial carcinomas arising in the background of high-grade carcinoma: a targeted next-generation sequencing study

Ekaterina Olkhov-Mitsel et al.

Summary: This study investigated the molecular landscape of dedifferentiated endometrial carcinoma (DEC) by targeted genomic sequencing and immunohistochemical analysis on seven DEC-HG and four DEC-LG cases. The results showed similar frequency and spectrum of mutations between DEC-HG and DEC-LG. The findings support expanding the definition of DEC to include DEC-HG, a previously under-recognised phenomenon with genomic similarities to DEC-LG.

HISTOPATHOLOGY (2023)

Add to Collection

Article Cell Biology

ZEB1 expression is frequently detected in undifferentiated and de-differentiated carcinomas, but is not specific among endometrial carcinomas

Atsushi Kihara et al.

Summary: Immunostaining for ZEB1 is a sensitive and specific method for detecting undifferentiated components of UC/DCs and distinguishing them from G3ECs, though it is not entirely specific for UC/DCs. Careful examination is needed to exclude other tumors such as less differentiated G3ECs, neuroendocrine carcinomas, and carcinosarcomas.

HISTOPATHOLOGY (2022)

Add to Collection

Article Cell Biology

Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasis

Yun Zhang et al.

Summary: Loss of PRC2 or KMT2D-COMPASS enables distinct epithelial-mesenchymal transition (EMT) trajectories in carcinoma cells, with differing effects on metastatic ability. These findings provide insight into how carcinoma cells control their entrance into and residence in different states, and which states are favorable for metastasis.

NATURE CELL BIOLOGY (2022)

Add to Collection

Article Pathology

Loss of dimethylated H3K27 (H3K27me2) expression is not a specific marker of malignant peripheral nerve sheath tumor (MPNST): An immunohistochemical study of 137 cases, with emphasis on MPNST and melanocytic tumors

Judith Jebastin Thangaiah et al.

Summary: Loss of H3K27me2 is not specific to MPNST and is also seen in other tumors, especially those in the blue nevus family.

ANNALS OF DIAGNOSTIC PATHOLOGY (2022)

Add to Collection

Review Oncology

Clinico-pathological significance of TCGA classification and SWI/SNF proteins expression in undifferentiated/dedifferentiated endometrial carcinoma: A possible prognostic risk stratification

Angela Santoro et al.

Summary: This study evaluated the clinico-pathological significance of TCGA molecular groups and SWI/SNF protein expression in undifferentiated/dedifferentiated endometrial carcinoma (UEC/DDEC). The findings suggest that POLE-mutant cases exhibit a good prognosis, while SWI/SNF-deficient cases have a poor prognosis. Other TCGA molecular subtypes appear to have an intermediate biological behavior.

GYNECOLOGIC ONCOLOGY (2021)

Add to Collection

Article Cell Biology

Undifferentiated endometrial carcinoma arising in the background of high-grade endometrial carcinoma - Expanding the definition of dedifferentiated endometrial carcinoma

Aurelia Busca et al.

HISTOPATHOLOGY (2020)

Add to Collection

Article Pathology

Histone H3K27 dimethyl loss is highly specific for malignant peripheral nerve sheath tumor and distinguishes true PRC2 loss from isolated H3K27 trimethyl loss

Dylan M. Marchione et al.

MODERN PATHOLOGY (2019)

Add to Collection

Article Clinical Neurology

Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas

Kristian W. Pajtler et al.

ACTA NEUROPATHOLOGICA (2018)

Add to Collection

Article Clinical Neurology

Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence

Leah M. Katz et al.

ACTA NEUROPATHOLOGICA (2018)

Add to Collection

Article Oncology

Integrated Molecular Characterization of Uterine Carcinosarcoma

Andrew D. Cherniack et al.

CANCER CELL (2017)

Add to Collection

Article Pathology

Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics

Inga-Marie Schaefer et al.

MODERN PATHOLOGY (2016)

Add to Collection

Article Biochemistry & Molecular Biology

PRC2 and SWI/SNF Chromatin Remodeling Complexes in Health and Disease

Cigall Kadoch et al.

BIOCHEMISTRY (2016)

Add to Collection

Article Pathology

Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas

Mackenzie Coatham et al.

MODERN PATHOLOGY (2016)

Add to Collection

Article Oncology

Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade Gliomas

Sebastian Bender et al.

CANCER CELL (2013)

Add to Collection

Review Multidisciplinary Sciences

The Polycomb complex PRC2 and its mark in life

Raphael Margueron et al.

NATURE (2011)

Add to Collection

Article Obstetrics & Gynecology

Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: A new type of dedifferentiated carcinoma?

EG Silva et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.